Tim MBA - Biogen Head Relations

IDP Stock  EUR 161.35  1.55  0.95%   

Executive

Tim MBA is Head Relations of Biogen Inc
Address 225 Binney Street, Cambridge, MA, United States, 02142
Phone617 679 2000
Webhttps://www.biogen.com

Biogen Management Efficiency

The company has return on total asset (ROA) of 0.0614 % which means that it generated a profit of $0.0614 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0739 %, meaning that it generated $0.0739 on every $100 dollars invested by stockholders. Biogen's management efficiency ratios could be used to measure how well Biogen manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 26.6 B. The current Net Tangible Assets is estimated to decrease to about 3.1 B
Biogen Inc has accumulated 11.18 B in total debt with debt to equity ratio (D/E) of 0.72, which is about average as compared to similar companies. Biogen Inc has a current ratio of 2.08, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biogen until it has trouble settling it off, either with new capital or with free cash flow. So, Biogen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biogen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biogen to invest in growth at high rates of return. When we think about Biogen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

EXECUTIVE Age

John ErwinMethode Electronics
58
Mark ShermetaroMethode Electronics
N/A
Karen KeegansMethode Electronics
60
Bradley CorrodiMethode Electronics
N/A
Kerry VyverbergMethode Electronics
57
Stacie SchulzMethode Electronics
47
Lars UllrichMethode Electronics
N/A
Hong ZhangChina Yongda Automobiles
42
Frederic MllerElma Electronic AG
46
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. BIOGEN INC operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 9100 people. Biogen Inc (IDP) is traded on Frankfurt Exchange in Germany and employs 7,500 people. Biogen is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Biogen Inc Leadership Team

Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Viehbacher, CEO President
Robin Kramer, Executive CFO
Sanjay Jariwala, VP Medical
Ginger Gregory, Executive Officer
Susan Esq, Executive Officer
Michael CPA, Ex CFO
Natacha Gassenbach, Chief Affairs
Tim MBA, Head Relations
Nicole Murphy, Executive Technology
Michael Hencke, Head Relations
Sean Godbout, Chief Controller
Anabella Villalobos, Head Sciences
Adam Keeney, Executive Development
MPH MD, Executive Development
Guy Hadari, Chief Officer

Biogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Biogen's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.